---
$id: https://graph.org.ai/products/commodity/51181630
$type: Product
source: UNSPSC
code: "51181630"
title: "Thiamazole"
class: "51181600"
classTitle: "Thyroid and antithyroid drugs"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Thiamazole

**UNSPSC Code**: 51181630
**Class**: [Thyroid and antithyroid drugs](Thyroid and antithyroid drugs.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antithyroid agent with the molecular formula C4H6N2S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 554Z48XN5E, chemically known as 1,3-dihydro-1-methyl-2h-imidazole-2-thione but more generally known as methimazole, which bears U.S. National Institutes of Health Compound Identifier 1349907. European Medicines Agency schedules Thiamazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10967MIG. The term THIAMAZOLE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules methimazole in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary.

